Baker Avenue Asset Management, LP

Position in IQV — Iqvia Holdings Inc.

CIK 1432529 SAN FRANCISCO, CA

Position in IQV

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$453,294

+$205,500 QoQ

Shares Held

2,346

+61.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#662

of 1,082 holders

Holding Since

Dec 2021

10 quarters on record

Voting authority Sole 24% Shared 0% None 76%

Healthcare · as of Jun 30, 2026

Baker Avenue Asset Management, LP holds $28,937,634 across 12 Diagnostics & Research names. IQV ranks #7 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	35,467	$17,781,735
2	A	Agilent Technologies, Inc.	43,641	$5,796,834
3	DHR	Danaher Corp /De/	5,929	$1,129,355
4	ILMN	Illumina, Inc.	5,692	$1,000,824
5	NTRA	Natera, Inc.	2,915	$791,276
6	IDXX	Idexx Laboratories Inc /De	1,257	$661,735
7	IQV	Iqvia Holdings Inc. This page	2,346	$453,294
8	CRL	Charles River Laboratories International, Inc.	1,511	$342,679

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$453,294	2,346	+61.5%	Shares	Sole	2026-07-28
2026-03-31	$247,794	1,453	+53.9%	Shares	Sole	2026-05-12
2025-12-31	$212,787	944	+165.9%	Shares	Sole	2026-02-10
2023-09-30	$69,846	355	+1379.2%	Shares	Sole	2023-11-15
2023-06-30	$5,394	24	+71.4%	Shares	Sole	2023-08-14
2023-03-31	$2,784	14	-22.2%	Shares	Sole	2023-05-16
2022-12-31	$3,688	18	-98.2%	Shares	Sole	2023-02-14
2022-06-30	$223,065	1,028	+2.0%	Shares	Sole	2022-08-03
2022-03-31	$233,059	1,008	-2.0%	Shares	Sole	2022-05-16
2021-12-31	$290,322	1,029	—	Shares	Sole	2022-02-11
No filing history on record for this holder in this stock.